Summary
Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli Lilly's Cymbalta, and Otsuka/BMS's Abilify, along with the recent launch of the multimodal antidepressant, Lundbeck/Takeda's Brintellix, in January 2014, and the potential introduction of seven promising late-stage pipeline products into the market during the forecast period, from 2013 to 2023.
Cymbalta (duloxetine) is an antidepressant that belongs to the SNRI class. It was developed by Eli Lilly and initially launched in the US market in 2004. Regulatory approvals followed in 2005 in the 5EU, 2007 in Australia, and 2010 in Japan.
Scope
- Overview of Major depressive disorder, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Cymbalta including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Cymbalta for the top eight countries from 2013 to 2023.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan and Australia.
For further information on this report, please visit - http://www.radiantinsights.com/research/cymbalta-major-depressive-disorder-forecast-and-market-analysis-to-2023
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Major depressive disorder
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Cymbalta performance
- Obtain sales forecast for Cymbalta from 2013-2023 in the top eight countries (the US, France, Germany, Italy, Spain, the UK, Japan and Australia)
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Summary
Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period.
The report identifies and analyzes the key companies shaping and driving the Spinal fusion market. The report provides insight into the competitive Spinal fusion landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData's team of industry experts.
To Get More Details @ http://www.radiantinsights.com/research/medipoint-spinal-fusion-current-and-future-players
Scope
- Investigation of current and future market competition for Spinal fusion
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Spinal fusion in clinical practice.
Reasons to buy
- Gain a high level view of the trends shaping and driving the Spinal fusion market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/medipoint-spinal-fusion-current-and-future-players#tabs-4
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Sucralose is noncaloric and is a non- nutritive sweetener. Sucralose is mixed with dextrose or maltodextrin as bulking agent and is sold in the worldwide markets. Furthermore, Sucralose is the non-nutritive and highly stable sweeteners. It is majorly used in recipes with less sugar. In addition, It allows same-volume substitution and is also obtainable in granulated form.
Major use of sucralose is in several food and beverages products. These products are majorly used in no-calorie sweetener, that doesn’t leads to dental cavities. It is considered to be the safe consumption for diabetics and nondiabetics and does not impact the insulin levels. In addition, Sucralose is used as a replacement for natural sweeteners and other artificial sweeteners. These sweeteners are potassium, aspartame and acesulfame.
China has become one of the major production countries of sucralose. In addition, China’s sucralose production has been increasing rapidly concerned by world’s emerging demand. Many producers amplified their sucralose capacity and many novel producers joint the production in the past years. This is likely to impact the expansion of sucralose production all over the world over the forecast period.
For further information on this report, please visit - http://www.radiantinsights.com/research/global-and-chinese-sucralose-industry-2015-market-research-report
Rising number of producers coupled with growing capacity, the global competion in the market is constantly augmenting. This is impacting the current competition structure in the region. Also, these factors are likely to provide new opportunities to the market participants which will impact the sucralose industry demand. Modern production technologies are being adopted for the production of sucralose, as the demand is continuously increasing.
Over the past few years, china’s export volume for sucralose is expanding rapidly. This has improved the product quality and lowered the prices relatively. High demand from overseas market has impacted the Chinese sucralose industry in the past and is projected to affect the overall industry positively .In addition, in 2012, the export volume in China contributed for over 82% of the sucralose output.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Craniomaxillofacial (CMF) surgery is a highly specialized branch of orthopedic surgery that focuses on all aspects of facial and skull disorders. In this report, GlobalData covers the following segments: CMF plate and screw fixation, CMF distraction, cranial flap fixation, temporomandibular joint (TMJ) replacement, CMF bone graft substitutes, and thoracic fixation (rigid fixation only). Throughout the report, adoption patterns, procedure volumes, and market revenues for all the aforementioned segments are included. In addition, GlobalData included an analysis on the dural repair market, which consists of dural substitutes and dural sealants. However, procedure numbers and market revenues for dural repair are provided only for the US market.
The 5EU market remains an important arena for CMF devices. Market shares by country are included in the figures below for each of the EU markets covered in this report. The competitive landscape in the CMF space in Europe is similar to that in the US, with DePuy Synthes taking the lead. Given that the marketplace is dominated by global orthopedic devices manufacturers, with very few pioneering startup companies, the market shares were found to be very similar among the 5EU countries.
Read Complete Report with TOC: http://www.radiantinsights.com/research/medipoint-craniomaxillofacial-devices-5eu-analysis-and-market-forecasts
Scope
- An overview of Craniomaxillofacial Devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized EU Craniomaxillofacial Devices market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Craniomaxillofacial Devices.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Craniomaxillofacial Devices sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors
Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medical-devices
Reasons To Buy
- Understand the trends shaping and driving the EU Craniomaxillofacial Devices market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in EU Craniomaxillofacial Devices market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/medipoint-craniomaxillofacial-devices-5eu-analysis-and-market-forecasts#tabs-4
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in EU Craniomaxillofacial Devices market landscape? Identify, understand and capitalize.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Summary
Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expected to grow to just over 8.5 million individuals by 2023. The anti-TNFs have been effective in treating the signs and symptoms of RA and inhibiting progression to erosive bone disease. However, the landscape is quickly changing with the introduction of biosimilars, novel biologics, and a class of oral therapies known as JAK inhibitors, all of which will change the market dynamics between 2013 and 2023. With the anti-TNFs as extremely effective therapies for RA, the market is extremely competitive for new entrants and will undergo further pressure as biosimilars are approved and launch.
With the cost of biologic therapies being very high, at an annual cost of at least $25,000, global healthcare systems need a reprieve from the expense. On September 9, 2013, Hospira's Inflectra and Celltrion's Remsima, which are both biosimilars of J&J's Remicade, were approved by the European Commission (EC) for marketing in the EU for multiple autoimmune diseases, including RA, Crohn's disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Remsima and Inflectra have been rolled out in selected European markets, although their launch in the 5EU is still pending due to potential intellectual property protections in these healthcare markets. The US-based generics company, Hospira, will market Inflectra in the EU, while the South Korean biotechnology company, Celltrion, the original developer of the infliximab biosimilar, will do so as well, but under the brand name Remsima, based on a collaboration forged between the two companies in 2009.
Read Complete Report with TOC: http://www.radiantinsights.com/research/biosimilars-rheumatoid-arthritis-forecast-and-market-analysis-to-2023
Scope
- Overview of Rheumatoid Arthritis, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Biosimilars including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Biosimilars for the top 10 countries from 2013 to 2023.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan, Australia, China and India.
Reasons To Buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Rheumatoid Arthritis.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of Biosimilars performance.
- Obtain sales forecast for Biosimilars from 2013-2023 in top 10 countries (the US, France, Germany, Italy, Spain, the UK and Japan, Australia, China and India).
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Summary
"Global Wind Turbine Value Chain - Production, Market Share, Competitive Landscape and Market Size to 2020" is the latest report from industry analysis specialists GlobalData, offering a comprehensive understanding of the wind power industry.
The report provides an overview of the global wind power market, examining major drivers and restraints and global wind power capacity and generation data broken down by region, country, and segment (onshore/offshore). It also looks at the wind turbine market, covering global average turbine size, price, market size, and manufacturer share in terms of installations.
The report discusses the global wind turbine value chain, examining the key components of a wind turbine: the rotor blade, gearbox, tower, and generator. It analyzes the production, cost, market size and major trends for each component, as well as major companies' competitive landscapes.
To Get More Details @ http://www.radiantinsights.com/research/global-wind-turbine-value-chain-production-market-share-competitive-landscape-and-market-size-to-2020
The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData's team of industry experts.
Scope
- Installed capacity and generation data for the 2001-2020 period, broken down by region, country, and segment
- Analysis of market forces in the wind power industry
- Information on global average turbine size and price, and market size and share
- Competitive landscape of major component manufacturers in the wind turbine value chain
- Cost analysis, market size and production for rotor blades, gearboxes, and generators
- Cost analysis and market size for wind turbine towers
- Analysis of major trends affecting key wind turbine components
To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/global-wind-turbine-value-chain-production-market-share-competitive-landscape-and-market-size-to-2020#tabs-4
Reasons To Buy
The report will allow you to -
- Facilitate decision-making based on strong historical and forecast data
- Position yourself to gain the maximum advantage from the industry's growth potential
- Develop strategies based on information on key wind turbine components
- Identify key partners and business development avenues armed with an understanding of key market issues
- Respond to competitors' business structures, strategies and prospects
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Glaucoma is a leading cause of preventable blindness globally. This chronic progressive optic neuropathy causes irreversible vision loss through damage to the optic nerve. There are currently no treatments that can directly prevent this damage, and all commercially available glaucoma therapies focus on lowering elevated intraocular pressure (IOP), a known risk factor for glaucoma development and progression. The launch of fixed-dose combination (FDC) products, which combine drugs from these various classes, will continue to be a source of significant growth in this market. The glaucoma market is about to enter a phase of new growth with the arrival of first-in-class drugs, such as Aerie's Rhopressa, Bausch & Lomb's Vesneo (latanoprost bunod), and Inotek's trabodenoson into the 7MM during the forecast period, which will generate additional growth in the global glaucoma market.
Highlights
Key Questions Answered
- The glaucoma market has been dominated by prostaglandin analogue (PGA) drugs in the last decade. New classes of drugs are anticipated the reach the market within the forecast period. How will these change the position the PGA drugs hold during the forecast period? Will these drugs maintain their market dominance in 2023?
- The current late stage glaucoma pipeline is varied, with first-in-class drugs in development with innovative modes of action. Which of these will have the biggest impact on the market? What strategies are developers undertaking to penetrate this crowded and highly generic market? Will these fulfil any unmet needs?
- Population aging is occurring in almost all countries worldwide, particularly in the 7MM. This is expected to have a significant impact on the prevalence of age-related diseases such as glaucoma. How will epidemiological changes impact the growth of the future market?
Read Complete Report with TOC: http://www.radiantinsights.com/research/pharmapoint-glaucoma-global-drug-forecast-and-market-analysis-to-2023
Key Findings
- The main driver of growth in the glaucoma market will be the introduction of first-in-class drugs over the forecast period. The launch of three first-in-class therapies will grow this market. New fixed-dose drugs entering the 7MM will also act as a stimulant for growth.
- The biggest barrier for growth in the glaucoma market will be the increasing use of generic latanoprost across the 7MM. The low cost of this therapy will increase the pressure on new drugs hoping to enter these markets to show drug cost-effectivness. This is likely to have a negative impact on these markets, as regulatory bodies are adopting stricter criterial for new drug approvals and reimbursement listing.
- The largest unmet needs mainly reflect the notorious problem of poor patient adherence to therapy. Simplifying dosing regimens is an important consideration for companies developing drugs to treat these patients.
Scope
- Overview of glaucoma, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized Glaucoma market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the glaucoma therapeutics market.
- Pipeline analysis: focus on the eight late-stage pipeline glaucoma drugs discussing emerging trends as well as overview of earlier phase drugs.
- Analysis of the current and future market competition in the global glaucoma therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/pharmapoint-glaucoma-global-drug-forecast-and-market-analysis-to-2023#tabs-4
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global glaucoma therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global glaucoma therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global glaucoma therapeutics market from 2013-2023.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
The SOA applications middleware market is anticipated to reach USD 8.2 billion by 2016. It had a prior market value of USD 3.5 billion in 2009.
Services oriented architecture (SOA) allows implementing the same code for different operations. It lets you make changes in individual services instead of the main application. This lets you integrate distinct platforms over multiple platforms. Middleware applications handle the exchange of information between client and service. These applications are embedded in drivers of the respective communication ports.
SOA capabilities help systems to communicate through a standardized approach. Systems can be added or replaced without having to rewire existing connections between systems. Reduction in IT complexity and knowledge needed to connect systems. Increase in business ability to use information and systems more rapidly to respond to market needs.
Detailed report at: http://www.radiantinsights.com/research/global-soa-applications-middleware-market-research-report-2015
Lack of security and testing space is an onus on the SOA applications middleware market. But the advent of cloud computing is expected to change the market landscape. Benefits of collaboration with business partners and transparent channels of communication will aid in market growth.
Message-oriented, intelligent, and content-centric are the different types of middleware currently offered in the market. MOM (message-oriented middleware) handles the exchange of messages between distinct systems through messages. This is managed via an enterprise messaging system. Intelligent middleware collects intelligence through agents. It monitors sensors to produce usable business data. Content-centric allows you to retain information according to unique requirements.
Applications of the SOA applications middleware market include Platform as a Service and Infrastructure as a Service (IaaS). Systems need quick response time and continuous online presence. Companies have adopted SOA and embedded it as part of their business model.
To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/global-soa-applications-middleware-market-research-report-2015#tabs-4
Major vendors of the SOA applications middle market are Oracle Corporation, IBM, Microsoft, Red Hat, and Solace Systems. IBM was the highest revenue grosser in 2011 and expects to dominate till 2016. The market will experience significant growth on account of distributed nature of systems.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Chinese Automobile Market obtained the maximum growth in the year 2013. In addition, it increased the output by more than 14.8% YoY to 22 million. The sales volume of the China SUV Industry attained over 13.92% YoY and crossing over 21 million. This has lead to the growth in Passenger car segment with increase in output and sales volume. Owing to the huge base of the current market, growth rate of china’s passenger car market will be reduced by 10%. Furthermore, Chinese SUV industry observed rapid development in 2013 with a higher growth rate than the passenger car market and total car market. This increased the industry output by 2 million, hence augmenting the 50% of the sales volume. The total sales volume increased from 49.3% YoY to 2.99 million. Nowadays, SUV has become more in demand and more popular among the Chinese customers. By 2018, SUV market since past few years is growing rapidly. Its sales volume is likely to cross over 7 million by 2018.
The SUV sub- compact industry has experienced considerable growth in the regions like Mexico, United States, India and China. This is majorly due to its compactness and low cost nature. Also, high maneuverability and stylish design of the sub compact SUV will augment the market demand for china SUV. High fuel efficient of SUV;s than passenger cars owing to its small engine , rebate and compact body on excise duty in various countries is the major factor augmenting the industry demand.
Browse the full “SUV Market” Report at: http://www.radiantinsights.com/research/china-suv-industry
The sub-compact SUV and Asia-Oceania SUV market is anticipated to go through maximum CAGR over the forecast period. Availability of economical domestic resources, strong governmental supports and developing economies in the regions like China and India will impact the overall industry growth positively. Furthermore, cost effective labor in china is the major factor expanding the SUV’s industry in china. This is projected to increase the China SUV industry demand over the forecast period.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
In 2012, the overall industry for epilepsy therapeutics in the major developed markets contributed for an approximate share of over $3.1 billion. Furthermore, this market is anticipated to expand at a total CAGR of over 3.3% to cross over $4.2 billion over the forecast period till 2019.
Epilepsy is described by recurring seizures as it is a set of long-term neurological disorders. When a group of neurons in brains or nerve cells send wrong signals, episodes of these seizures occur. Depending on the cause of the epilepsy, seizures may possibly be different from primary comprehensive seizures to partial seizures. Patients suffering from epilepsy act weirdly and grumble about strange sensations and emotions. People of all ages are being affected by epilepsy as it is the fourth most common disorder. Doctors prescribe drugs or antiepileptic medicines for the treatment of epilepsy. It depends on the age of the patient seriousness of the seizures and type of seizures to be treated
View More Details of "Epilepsy Therapeutics Industry" @ http://www.radiantinsights.com/research/epilepsy-therapeutics-in-major-developed-markets-to-2019-new-aeds-with-novel-mechanisms-of-action-signal-a-shift-in-treatment-patterns
Recent approvals of drugs coupled with novel technologies of action are some of the factors attributing to the industry growth of the market. The U.S region contributes to the major market share for over 55% for the total market. In addition, three new anti-epileptic drugs have been permitted in the aforementioned region since 2012. Fycompa, Trobalt and Aptiom are also projected to be launched over the coming years. Moreover, brivaracetam is likely to approve over the coming years. Factors such as improved safety and tolerability of fycoma and trobalt are also contributing significantly owing to the increased interest of prescribers over the past few years.
Constant uptake of anti-epileptic drugs of second and third generation is anticipated to attribute towards the revenues in these regions. Although, the market could experience the hindering impact of geriatric competition as a result of novel patent expiries in all the key industries especially for key branded drugs like Lamictal and Keppra.
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/epilepsy-therapeutics-in-major-developed-markets-to-2019-new-aeds-with-novel-mechanisms-of-action-signal-a-shift-in-treatment-patterns#tabs-4
Key market players operating for epilepsy therapeutics in the major developed markets are Novartis AG, GlaxoSmithKine plc, Shire, Johnson & Johnson Pfizer, Sanofi S.A, Cephalon, Abbot Laboratories, Sunovion Pharmaceuticals, Shire and Valeant Pharamceutical International Inc.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
The global Movable Bag Filter Market is projected to grow at a 5.8% CAGR over the forecast phase (2015-2020). Government regulations aimed at reducing particle emission from various industries is anticipated to fuel market demand. Recent rise of the mining and cement industries will fuel market development in the years ahead. Advances in technology and development of new media and design of filters are expected to drive market demand.
Bag filters or baghouse filters is a pollution control device which removes particles from gas or air released in chemical processes. Steel mills, pharmaceuticals, food manufacturers and power plants are end-users which employ bag filters to control their emission. These filters are made from felted material.
Shaker, pulse jet, and reverse-air bag filters are products of the market. Shaker bag filters are used continuously in a batch process. They are available in a range of small to large compartmentalized units. Reverse air filters collects dust inside the bags and cleaned by pumping clean air in the reverse direction. Pulse jet filters are individual bags encased in a metal cage. Pulse jet is the leading product owing to its wide application in food & beverages, municipal waste, chemicals, sinter plants, and pharmaceutical industries.
To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/global-movable-bag-filter-market-research-report-2015#tabs-4
Woven and non-woven are 2 types of bag filters. Non-woven is used in high energy cleaning systems, while woven are used in low-end systems. Non-woven fabrics are used by pulse jet filters. Woven filters employ different weaving patterns to trap dust particles. They are used in reverse-air or shake bag filters.
Applications of the market are mining, power generation, pulp & paper, cement, pharmaceutical, chemical, and municipal waste. Bag filters are a must in power plants which are used to generate electricity or used in waste management. Food industries will display a significant growth rate due to strict regulations placed on food processing and manufacturing. Need for high quality air is expected to drive the global movable bag filter market. Dispensing dust and fumes in the metal processing industry will provide new opportunities.
Key players of the global movable bag filter market are Pall Corporation, Thermax Ltd., Donaldson, BWF Envirotec, and Eaton.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Mineral acids refer to acids obtained from one or even more inorganic composites. Each mineral acid leads to the formation of hydrogen & conjugate base ions when water-dissolved. Some of the most regularly used mineral acids are hydrochloric acid, nitric acid, and sulfuric acid.
Mineral acids vary from strong to moderate and weak ones. They have a tendency for being insoluble in organic solvents and soluble in water. Mineral acids also find applications across the industry of chemicals. They serve as raw materials for the manufacture of inorganic & organic chemicals.
Huge amounts of these acids are synthesized for industrial applications in big plants. Mineral acids are even used directly for their corrosive features. These features favor the market and propel its revenues. The China mineral acid market is predicted to generate operating sales of around RMB 94.4 billion by 2017. From January to December 2012, market manufacturing earned about RMB 90.4 billion.
Browse the full “Mineral Acids Market” report at: http://www.radiantinsights.com/research/china-mineral-acid-industry
Sulfuric acid accounted for the largest consumption in 2012. It boasted of a domestic utilization of nearly 77.6 million tons that year. Sulfuric acid was followed by hydrochloric acid (8.9 million tons) and nitric acid (2.8 million tons) in 2012. The forthcoming market may face pressure from optimization promotions and industrial structural innovations.
Additionally, it may encounter pressure from ‘backward production capacity’ eliminations. However, in terms of policies, the national twelfth five year plan states growth in the industry of chemical raw materials, opening decent prospects for the China mineral acid market. Thus, in the years ahead, the market could experience sluggish expansion and lay more emphasis on structural amendments.
This market is analyzed on various grounds. Some of these comprise sales, size, profitability, consumption, productivity, and export & import circumstances. Fiscal status, profiles, costs, geographical regions, and product kinds & revenues are the rest of the grounds on the basis of which the market is studied. Strategies adopted by thirteen key firms ensure huge market contribution.
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/china-mineral-acid-industry#tabs-4
Huge demand in China across its application & end-user segments is also projected to further the sales of the China mineral acid market.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
"Biopower in Malaysia, Market Outlook to 2025, Update 2015 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Biopower market in Malaysia.
The report provides an in-depth analysis on global renewable power market and global Biopower market with forecasts up to 2025. The report analyzes the power market scenario in Malaysia (includes conventional Hydro, nuclear and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes Wind, small hydro, biopower and renewable) and provides forecasts up to 2025. The report Highlights installed capacity and power generation trends from 2001 to 2025 in Malaysia Biopower market. A detailed coverage of energy policy framework governing the market with specific policies pertaining to Biopower market development is provided in the report. The research also provides company snapshots of some of the major market participants.
Scope
The report analyses global renewable power market, global biopower (Biomass and Biogas) market, Malaysia power market, Malaysia renewable power market and Malaysia biopower market. The Scope of the research includes -
- A brief introduction on global carbon emissions and global primary energy consumption.
- An overview on global renewable power market, highlighting installed capacity trends, generation trends and installed capacity split by various renewable power sources. The information is covered for the historical period 2001-2014 (unless specified) and forecast period 2015-2025.
Browse the full “Biopower Market” report at: http://www.radiantinsights.com/research/biopower-in-malaysia-market-outlook-to-2025-update-2015-capacity-generation-levelized-cost-of-energy-lcoe-investment-trends-regulations-and-company-profiles
- Renewable power sources include wind (both onshore and offshore), solar photovoltaic (PV), concentrated solar power (CSP), small hydropower (SHP), biomass, biogas and geothermal.
- Detailed overview of the global biopower market with installed capacity and generation trends, installed capacity split by major biopower countries in 2014 and key owners information of various regions.
- Power market scenario in Malaysia and provides detailed market overview, installed capacity and power generation trends by various fuel types (includes thermal conventional, nuclear, large hydro and renewable energy sources) with forecasts up to 2025.
- An overview on Malaysia renewable power market, highlighting installed capacity trends (2001-2025), generation trends(2001-2025) and installed capacity split by various renewable power sources in 2014.
- Detailed overview of Malaysia biopower market with installed capacity and generation trends and major active and upcoming biopower projects.
- Deal analysis of Malaysia biopower market. Deals are analyzed on the basis of mergers, acquisitions, partnership, asset finance, debt offering, equity offering, private equity (PE) and venture capitalists (VC).
- Key policies and regulatory framework supporting the development of renewable power sources in general and biopower in particular.
- Company snapshots of some of the major market participants in the country.
Request Free Sample Of This Study @ http://www.radiantinsights.com/research/biopower-in-malaysia-market-outlook-to-2025-update-2015-capacity-generation-levelized-cost-of-energy-lcoe-investment-trends-regulations-and-company-profiles#tabs-4
Reasons to buy
- The report will enhance your decision making capability in a more rapid and time sensitive manner.
- Identify key growth and investment opportunities in Malaysia biopower market.
- Facilitate decision-making based on strong historic and forecast data for wind power market.
- Position yourself to gain the maximum advantage of the industry's growth potential.
- Develop strategies based on the latest regulatory events.
- Identify key partners and business development avenues.
- Understand and respond to your competitors' business structure, strategy and prospects.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
Summary
"Plant Life Extension (Plex) for Nuclear Power, Update 2015 - Global Market Size, Competitive Landscape and Key Country Analysis to 2025", the latest report from industry analysis specialist GlobalData, offers comprehensive information and analysis of the global nuclear plant life extension (PLEX) market.
The report provides a clear overview of and detailed insight into the global PLEX market. It explains the key drivers and challenges affecting the market and also provides data regarding historic and forecast market size, both globally and in the key nuclear power market countries: US, Canada, UK, France, Russia, Ukraine, Japan, and South Korea.
The report uses data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData's team of industry experts.
To Get More Details @ http://www.radiantinsights.com/research/plant-life-extension-plex-for-nuclear-power-update-2015-global-market-size-competitive-landscape-and-key-country-analysis-to-2025
Scope
- Detailed historic and forecast statistics for cumulative nuclear capacity and annual electricity generation from 2006 to 2025, globally and for each of the key countries.
- Coverage of the key growth drivers and challenges related to the global PLEX market.
- Coverage of number of reactors starting PLEX, combined capacity of all plants starting PLEX, and the market size of PLEX for each year during 2006-2025, at a global, regional and key country level.
- Competitive landscape discussing PLEX activities undertaken by all the market contenders.
Reasons to buy
- Facilitate decision-making based on strong historic and forecast data for the wind turbine O&M market
- Maximize potential in the growth of the wind power market
- Identify key partners and business-development avenues
- Respond to competitors' business structure, strategy and prospects.
About Us
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Website: Radiant Insights
